Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Current Hematologic Malignancy Reports|April 29, 2010
Prognostic factors in low-grade non-Hodgkin lymphomasMassimo Federico, Stefano Molica, Monica Bellei, et al.
Hematological Oncology|November 17, 2019
Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years onStefano Molica, Estella Matutes, Constantine Tam, et al.
Haematologica|June 1, 2005
Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapyStefano Molica, Angelo Vacca, Luigi Tucc, et al.
Expert Review of Hematology|July 3, 2026
Embedding cardiovascular risk assessment into routine BTK inhibitor management in chronic lymphocytic leukemiaStefano Molica, Stefano Oliva, Giuliana Farina, et al.
Cancers|July 29, 2023
Advancements in the Treatment of CLL: The Rise of Zanubrutinib as a Preferred Therapeutic OptionStefano Molica, Constantine Tam, David Allsup, et al.
Haematologica|July 3, 2025
Ibrutinib versus acalabrutinib in fixed-duration chronic lymphocytic leukemia therapy: a comparative analysis of efficacyStefano Molica, Tait D Shanafelt, Diana Giannarelli, et al.
American Journal of Hematology|December 15, 2023
Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age- and sex-matched populationStefano Molica, Tait D Shanafelt, David Allsup, et al.
Biochimica Et Biophysica Acta|July 28, 2004
Cytosolic carbonic anhydrase activity in chronic myeloid disorders with different clinical phenotypeGiuseppe Bonapace, Francesco Iuliano, Stefano Molica, et al.
Pageof 16